Guest guest Posted February 20, 2008 Report Share Posted February 20, 2008 Dear Group: I have had CML for five years and have recently developed the G250E mutation which, I understand, is sensitive to both dasatinib and nilotinib. I am now on 800 mg. of imatinib but PCR has gradually risen over the past months from neglible to .5% PCR from the bone marrow and .3% PCR from peripheral blood. FISH is 0/500 down from 2/500 about a month ago. Cytogenetics are pending. My doc at MSKCC, who is considering switching me to dasatinib says the response data for patients for both these drugs is rather sparse. Does anyone have info. or data on the G250E mutation and which drug is most effective? I looks as if Gleevec and I will be getting a divorce. Many thanks, Carl Davies town, PA, USA --------------------------------- Looking for last minute shopping deals? Find them fast with Search. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.